Marc Shenouda, CEO and Co-Founder of Neuropeutics Inc., gives insights into targeted therapeutics for neurodegenerative disease, winning the AbbVie Biotech Innovator’s Award, and earlier detection for ALS.
Share this post
S14 E02 Developing Disease Modifying Therapeutics for ALS at Neuropeutics
National Pharmaceutical Congress (NPC) Podcast
Created in response to industry requests, NPC Podcast hosts Jim Shea, Mark McElwain and Mitch Shannon interview an esteemed series of guests with pertinent questions about the pharma industry.
Created in response to industry requests, NPC Podcast hosts Jim Shea, Mark McElwain and Mitch Shannon interview an esteemed series of guests with pertinent questions about the pharma industry.
Appears in episode
Jeremy Visser
Recent Episodes
Share this post